---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-052872"
form_type: "8-K"
ticker: "HSCS"
cik: "0001468492"
company_name: "HeartSciences Inc."
filed_at: "2026-05-06T23:59:59+00:00"
generated_at: "2026-05-14T22:36:20.648753+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# HeartSciences annual meeting approves director, stock plan, auditor; officer exculpation fails

## Summary
- Andrew Simpson re-elected Class III director with 577,840 for, 107,738 withheld, 1,288,285 broker non-votes.
- Amendment to 2023 Employee Stock Purchase Plan approved, increasing reserved shares to 1,250,000.
- Proposal to amend certificate of formation for officer exculpation under Texas law did not pass; needed majority of outstanding shares.
- Haskell & White LLP ratified as independent auditor for FY2026 with 1,872,912 votes for.
- Adjournment proposal approved (1,784,662 for) to allow further proxy solicitation if needed.

## SEC filing metadata
- accession: 0001213900-26-052872
- form_type: 8-K
- ticker: HSCS
- cik: 0001468492
- company_name: HeartSciences Inc.
- filed_at: 2026-05-06T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1468492/000121390026052872/0001213900-26-052872-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1468492/000121390026052872/ea0289301-8k_heart.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-052872
- JSON: https://secwatch.observer/filing/0001213900-26-052872.json
- Plain text: https://secwatch.observer/filing/0001213900-26-052872.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.